Self-Test for Covid-19: The Indian Council of Medical Research advised that these tests are only for those who have symptoms of Covid or someone who has come into contact with people or places at risk of contracting the Covid virus …
New Delhi. Atmanirbhar Bharat made a batch of Covid tests, and went one step further. With this kit, people will now be able to find samples in their homes by taking samples from their noses, whether it is positive or negative. The Indian Council of Medical Research (ICMR) has recognized this group called Coviself. This kit was developed by Pune-based molecular company MyLab Discovery Solutions. But as soon as anything related to medicine is brought up in the market, all kinds of questions start to pop up in our minds, especially if we have to use them ourselves.
How will the group prove useful?
With the arrival of the second wave, as hospitals across the country faced shortages of space and medicines, as the number of patients increased, the laboratory was also pressured to test for COVID and the whole country was facing a Covid test crisis. Due to the increasing pressure on the laboratory for testing Kovid, it took 3-4 days for RTPCR, which is considered the most reliable in the Kovid test. This led to delays in hospitalization and treatment of patients, which led to the transformation of the epidemic into a more serious situation, which led to the change of guidelines regarding screening for Covid also from time to time. In such a case, Kovid Administration is expected to gain new momentum in India due to the introduction of the Self-Test Kit.
Then long waiting lists in the laboratory, delays in reporting, arbitrary recovery of investigation, and delays in treatment due to late reports, will be able to eliminate all kinds of problems such as collecting samples from homes. Also, this group will be able to tell whether it is negative or positive in just 15 minutes, since the treatment of the patient will start in time and the spread of infection can also be prevented. The self-test kit was first permitted in the United States last November. Lusira Health Rapid Test Kit was permitted for use during an emergency. Later it was also allowed in Europe and South Korea.
What’s in the kit?
A group called Coviself was developed by Mylab Discovery Solution, a Pune-based molecular company. Rapid antigen is used as a test, reported in just 15 minutes. For this, a swab is taken from the nose to check for the virus. The investigation process takes no more than 2 minutes. The price of this group has been kept at Rs 250. Meanwhile, compared to this, RT-PCR test costs Rs 400-1500 and if you go to lab for antigen test then you have to do it. Spend 300-900 rupees for that. These prices are different in different states. This kit will be available in the market next week.
Currently, My Lab can produce 70 lakh kits per week, which is planned to increase to Rs 1 crore group per week in the next 15 days. This kit will be available on 7 chemists and e-pharmacy portals across India. A company mobile app will also be released with this group that is easy to test, investigators can put their reports directly on this app, and these results will be accessed directly in the Indian Medical Research database, thus the number of patients in India and their information can easily be monitored.
Way to check
The kit consists of a prefilled delivery tube, an extraction tube, a sterile nasal swab (to be sampled inside the nose), a test card, and a biological pouch (which can be placed safely in the trash after the examination)) included. First of all, you have to download the Coviself app on your phone and put your information in it. The app will securely link all data to the ICMR portal, where all government investigations are located.
Before beginning the investigation, you must clean your hands and the place where you will keep the test kit. Then, the swab should be taken 2 to 4 cm inside your nose until it comes into contact with the back wall of your nose, rub it there and take a sample. Then the swab is rotated into the liquid pre-filled into an extraction tube. The tube is well closed. Next, two drops of the liquid leaving the tube are dropped onto the test card. Results are revealed within 15 minutes.
If someone is positive, two lines will appear on the test card and if it is negative, the same line will appear. If the result lasts more than 20 minutes or if the streak does not appear, this means that the investigation was not done correctly. After that, all items related to the test are placed in a biohazard bag and placed in a biomedical jacket.
What are the pros and cons of the investigation itself?
Instead of contacting a hospital, someone’s lab, or a home technician and testing them on their own, the risk of infection will be reduced. It is also a good idea to check yourself because one is cheaper, the other one will be able to avoid the hassle of numbering in the lab, plus it can reduce the stress on the lab, which has been operating for 24 hours for several hours for the past months. On the contrary, those who do not believe this investigation is correct have their arguments. Confusion continues in this investigation.
Also, how well the investigator applies the swab to the nose, the risk of contamination, or contamination of the swab stick is very high. Also, there is ample scope for false negative reports on the rapid antigen test. If someone reports negative and does not have symptoms, there is a risk of infection spreading from it. The biggest concern above all of these things is how honest people are in giving their information. If someone entered their address and number incorrectly, it would be difficult to track them.
How effective is the investigation itself?
If a patient follows isolation rules, self-examination can be very effective. According to the European Center for Disease Prevention and Control (CDC), the reliability of the investigation depends on some things, how well the sample was taken, how well the instructions for the investigation were followed, the time of sampling What was the viral load during that time?
According to a European CDC report in March, the investigation itself may narrow the scope of the investigation slightly, but it cannot replace the traditional investigation in any way. The purpose of this investigation should be to reduce the burden of the investigation, and it cannot be fully relied upon. But with the introduction of such investigations, managing epidemics such as COVID-19 can be balanced.